Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration. - Wikidata - wikimedia - TriplyDB

Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration.

Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration.

http://www.wikidata.org/entity/Q35652167

about

Oxidative Stress Signaling in Alzheimers Disease Uncovering novel actors in astrocyte-neuron crosstalk in Parkinson's disease: the Wnt/β-catenin signaling cascade as the common final pathway for neuroprotection and self-repair Parallels between major depressive disorder and Alzheimer's disease: role of oxidative stress and genetic vulnerability Neuronal failure in Alzheimer's disease: a view through the oxidative stress looking-glass Human wild-type full-length tau accumulation disrupts mitochondrial dynamics and the functions via increasing mitofusins.Tau physiology and pathomechanisms in frontotemporal lobar degeneration Cargo trafficking in Alzheimer’s disease: the possible role of retromer A Wnt1 regulated Frizzled-1/β-Catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: Therapeutical relevance for neuron survival and neuroprotection Paternal spatial training enhances offspring's cognitive performance and synaptic plasticity in wild-type but not improve memory deficit in Alzheimer's mice.Cognitive flexibility and long-term depression (LTD) are impaired following β-catenin stabilization in vivo.N-acetylcholinesterase-induced apoptosis in Alzheimer's disease Expression of S100A6 in rat hippocampus after traumatic brain injury due to lateral head acceleration.A common biological mechanism in cancer and Alzheimer's disease?The imprinted gene PEG3 inhibits Wnt signaling and regulates glioma growth Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease.Mitochondrial dynamics in Alzheimer's disease: opportunities for future treatment strategies.Platelet-derived growth factor-BB restores HIV Tat -mediated impairment of neurogenesis: role of GSK-3β/β-catenin.Platelet-derived growth factor CC-mediated neuroprotection against HIV Tat involves TRPC-mediated inactivation of GSK 3beta.Enhancing Beta-Catenin Activity via GSK3beta Inhibition Protects PC12 Cells against Rotenone Toxicity through Nurr1 Induction.CDK5 activator protein p25 preferentially binds and activates GSK3β Expression of Tau40 induces activation of cultured rat microglial cells.WW domain-containing oxidoreductase in neuronal injury and neurological diseases.Overexpression of tau downregulated the mRNA levels of Kv channels and improved proliferation in N2A cells.Mitochondrial dysfunction - the beginning of the end in Alzheimer's disease? Separate and synergistic modes of tau and amyloid-β toxicity Expression of 1N3R-Tau isoform inhibits cell proliferation by inducing S phase arrest in N2a cells.Differential modulation of Akt/glycogen synthase kinase-3beta pathway regulates apoptotic and cytoprotective signaling responses The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease.The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway.Hypothermic Preconditioning Reverses Tau Ontogenesis in Human Cortical Neurons and is Mimicked by Protein Phosphatase 2A Inhibition.Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.Hypothermia blocks beta-catenin degradation after focal ischemia in rats.Effects of microtubule-associated protein tau expression on neural stem cell migration after spinal cord injury.Sustained high levels of neuroprotective, high molecular weight, phosphorylated tau in the longest-lived rodent Accumulation of human full-length tau induces degradation of nicotinic acetylcholine receptor α4 via activating calpain-2.A Clinical Approach to the Diagnosis of Traumatic Encephalopathy Syndrome: A Review.Tau accumulation induces synaptic impairment and memory deficit by calcineurin-mediated inactivation of nuclear CaMKIV/CREB signaling Tau accumulation impairs mitophagy via increasing mitochondrial membrane potential and reducing mitochondrial Parkin The effect of mGluR2 activation on signal transduction pathways and neuronal cell survival.Phosphorylated tau: toxic, protective, or none of the above The Akt signaling pathway contributes to postconditioning's protection against stroke; the protection is associated with the MAPK and PKC pathways.

P2860

Q22241327-722B0B0D-45FF-4984-82B0-84593D58BE31 Q26865502-FFF4209C-E341-4D51-8D14-53EB77137848 Q27000066-889BF36F-A84F-4305-8E40-5C62C4DACDE3 Q27015785-DAE46F4F-28BD-4A04-9053-6412213896D5 Q27320038-E03183EF-9228-4CD6-A3D3-6F09078673E8 Q28070250-5E2E8766-B860-422F-A28F-2BC8D7B1D988 Q28268822-B964F5C3-DF59-43A5-A7F4-992422F1E520 Q28589470-BCE64C5D-6AD2-4728-9D7A-B1F9D791C090 Q29994749-4279FB45-01C7-4F7B-B3C5-495CAD0FF6C0 Q30580933-74EAEF9B-6489-4BD6-A1D4-DD3BEF8EFB80 Q33366506-BC268308-BEB7-4668-81D3-2C090A5C8028 Q33580678-4ECF8716-8C16-4ABA-B3F8-385347D488D4 Q33606991-A8172479-2A77-4E6C-B47D-FDD55E485037 Q33707208-7B1BEAA6-CA6F-446A-8B9C-CF146C7B0A49 Q33771694-B0071CA2-6A0C-4B85-9056-6385376CDDFF Q34073939-42B6E9FF-01CE-41E2-AA77-744F0F9B43EF Q34281340-7F9C5D06-41DB-4867-AE02-678BF4AD79CB Q34450960-0AA03B6B-CCC9-4ABD-B81A-2FE6CAB46863 Q34520848-8E4F5F92-BB24-45FE-B871-1A9210B8FCDD Q34525891-7C7B07F0-1B9F-48A0-A0E4-EE0B1322A0A1 Q35022620-D88BCD01-C42B-412A-8B44-084B0C1910CA Q35067919-807021EE-8D5A-4AD0-99F2-B66DE27DEF7B Q35543023-5D49630B-753F-4D32-A2AF-9BD007B687CB Q35579318-7753569A-8B7B-4BF8-A10E-AD2A9AABE928 Q35590240-27F3A7CF-FE59-4A08-ACB0-1E78C9F3BF8D Q35674485-264925BB-ED43-43DE-B1E2-D382CF3EFA4F Q35800000-90E58AE6-062A-4B3D-B028-7CAA44B7B5B0 Q35860566-0FAF3507-6224-40BB-A50D-9628503D6630 Q36538815-6AD854C0-4AD3-4984-B86E-7DF114BAB583 Q36573418-5A070B54-522D-43BF-BD2B-88973C234122 Q36597064-947DF48E-90DE-4D79-904E-C30814D37703 Q36737523-67162BBE-6445-4722-A0D2-BFD0C6513349 Q36907724-0076CDBF-DA2F-4BF8-A849-BD52A7507A6C Q36985823-C8EC0D2E-7D1F-432D-9131-B5C4D86B4DFC Q37040304-548782CF-59FA-4E08-9C36-47A15F0EB451 Q37065235-4A3BCBDE-B4C7-4922-B7A0-2774EFAF472D Q37109476-1A8D1B43-2EC7-48F1-8027-D649CE737DF0 Q37232609-A34E92A4-3552-49DD-B6C8-070A8C3CDCF1 Q37238262-8578FEA0-8868-4C13-804B-AADD740AA2A9 Q37352314-E069EC82-5E06-4FF1-9A5D-1F748C5A26A5

P2860

Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration.

http://www.wikidata.org/entity/Q35652167

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Phosphorylation of tau antagon ...... Alzheimer's neurodegeneration.

@ast

Phosphorylation of tau antagon ...... Alzheimer's neurodegeneration.

@en

type

label

Phosphorylation of tau antagon ...... Alzheimer's neurodegeneration.

@ast

Phosphorylation of tau antagon ...... Alzheimer's neurodegeneration.

@en

prefLabel

Phosphorylation of tau antagon ...... Alzheimer's neurodegeneration.

@ast

Phosphorylation of tau antagon ...... Alzheimer's neurodegeneration.

@en

P1433

Q35652167-1EFE579F-5194-4704-8EF2-28BAFA699832

P1476

Q35652167-0B331D7B-F0F1-4140-811B-1DCC9D46C07A

P2093

Q35652167-01ACFDA2-DF18-47C8-A881-B930BD1E5F2B

Q35652167-204AC166-86A6-4B60-8D05-457136546DA9

Q35652167-343B61B3-FF4D-4519-BB52-BFBE7E7C1377

Q35652167-7A4C931E-C7B6-4D2F-9214-EA52892D1351

Q35652167-8C2CFF6D-E0AD-49DC-805C-4DC6A507300E

Q35652167-9067DCF7-3B72-4ADA-9AE4-233E049887A4

Q35652167-9ECBD314-BA37-4339-9D1F-D200E8F3816E

Q35652167-ACFA6A7B-390E-4C07-B1CB-05C8B9CADB96

Q35652167-BA031CEE-51F3-44B0-8509-209D8839ABCF

Q35652167-BDC496F1-6045-4764-AB09-AB2B8D5FBD72

P2860

Q35652167-06BDCA3B-71E0-4C41-8B40-010E2094C09C

Q35652167-09DE787E-089C-40C1-A120-103C49FC797C

Q35652167-0A278C79-8733-444C-8BCB-F0E414D45A3A

Q35652167-0A52982C-A1F1-4CD0-87E3-30EE0BAC20CA

Q35652167-0C39AD6A-F8C9-4205-BB1D-533A8D24BDB5

Q35652167-0E88051B-C342-4CC5-B25D-9DB4C7F6561B

Q35652167-1085EEF5-150E-4332-91EF-1261F67F6834

Q35652167-2A33E69C-21D9-41CE-A20D-5AB549B15663

Q35652167-2B6A84A8-F4D3-4B5E-BC12-3A86D49AB171

Q35652167-2D1714A6-1C86-4F8D-8401-529BEDEDECFA

P304

Q35652167-B0AC73B4-9D58-45A7-B172-F92F274D8FE9

P31

Q35652167-8CC869A1-611C-4A75-9847-9BA34B3AC3EA

P356

Q35652167-57C99927-E2A6-4114-AD38-8E517C48D85A

P407

Q35652167-DB4AB0EF-2A8A-449B-B67C-F76210B6DF3A

P433

Q35652167-7D57CADC-0AA2-42F8-A735-6FD0B38A7A14

P478

Q35652167-58F5274A-4A92-42EC-B7F4-92D8A780CD91

P577

Q35652167-1114EA8E-9F19-4903-B558-DD49B88B3A4B

P5875

Q35652167-DCD03393-3E6F-49F5-AB94-36DAF966B4A6

P698

Q35652167-896603CD-6F00-4D48-8722-FE696C2D45D1

P921

Q35652167-1F9CD2E1-6B2B-47A3-A97A-904E55A46FA3

Q35652167-C8043EF7-5AE2-41B9-A338-A65EDE5BFCFF

P932

Q35652167-2BCEB4A7-9D2E-41A5-8834-A2F6807619B2

P356

PNAS.0609303104

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Phosphorylation of tau antagon ...... Alzheimer's neurodegeneration.

@en

P2093

Francesca-Fang Liao

http://www.w3.org/2001/XMLSchema#string

Hai-Hong Wang

http://www.w3.org/2001/XMLSchema#string

Hong-Lian Li

http://www.w3.org/2001/XMLSchema#string

Huaxi Xu

http://www.w3.org/2001/XMLSchema#string

Jia-Yu Zhang

http://www.w3.org/2001/XMLSchema#string

Jian-Zhi Wang

http://www.w3.org/2001/XMLSchema#string

Qing Tian

http://www.w3.org/2001/XMLSchema#string

Qun Wang

http://www.w3.org/2001/XMLSchema#string

Shi-Jie Liu

http://www.w3.org/2001/XMLSchema#string

Xiao-Chuan Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Tau phosphorylation in Alzheimer's disease: pathogen or protector?

Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3beta and its upstream regulators

Tau suppression in a neurodegenerative mouse model improves memory function

Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology

Neurodegenerative tauopathies

Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells.

Apoptosis in the nervous system.

Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau.

Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis).

P304

3591-3596

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0609303104

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

2007-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6445926

http://www.w3.org/2001/XMLSchema#string

P698

17360687

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

phosphorylation

P932

1805527

http://www.w3.org/2001/XMLSchema#string